Blystone Chad R, Lambright Christy S, Furr Johnathan, Wilson Vickie S, Gray L Earl
Department of Molecular Biomedical Sciences, North Carolina State University, Raleigh, NC 27695, USA.
Toxicol Lett. 2007 Nov 1;174(1-3):74-81. doi: 10.1016/j.toxlet.2007.08.010. Epub 2007 Aug 31.
Iprodione (IPRO) is a dichlorophenyl dicarboximide fungicide similar to procymidone and vinclozolin. All three of these fungicides induce Leydig cell tumors in the rat testis in long-term studies and an endocrine mode of action has been hypothesized to mediate this effect. Although both procymidone and vinclozolin antagonize the androgen receptor (AR) in vitro and in vivo, IPRO does not appear to be an AR antagonist. We proposed that pubertal exposure to IPRO would delay male rat pubertal development and reduce testosterone production within the testis. Sprague-Dawley weanling rats were dosed by gavage with 0, 50, 100, or 200mg/kg/day of IPRO from post-natal day (PND) 23 to 51/52. The onset of puberty (progression of preputial separation (PPS)) was measured starting on PND 37. Organ weights, serum hormones, and ex vivo testis steroid hormone production under stimulated (+human chorionic gonadotropin (hCG)) and unstimulated (-hCG) conditions were measured at necropsy. IPRO delayed PPS at 100 and 200mg/kg/day and decreased androgen sensitive seminal vesicle and epididymides weights at 200mg/kg/day. Furthermore, IPRO increased adrenal and liver weights at 200mg/kg/day, presumably by different mechanism(s) of action. Serum testosterone levels were decreased along with serum 17alpha-hydroxyprogesterone and androstenedione whereas serum LH was unaffected. IPRO reduced ex vivo testis production of testosterone and progesterone. Taken together, these results suggest that IPRO affects steroidogenesis within the testis, not through disruption of LH signaling, but possibly through enzyme inhibition of the steroidogenic pathway before CYP17. These data, along with the reported failure of IPRO to elicit an AR antagonism in vitro, provide evidence that IPRO differs from the dicarboximides procymidone and vinclozolin in that the effects on male rat pubertal development result from an inhibition of steroidogenesis and not AR antagonism.
异菌脲(IPRO)是一种二氯苯基二羧酰亚胺类杀菌剂,与腐霉利和乙烯菌核利类似。在长期研究中,这三种杀菌剂都会诱发大鼠睾丸中的莱迪希细胞肿瘤,并且推测其内分泌作用模式介导了这种效应。尽管腐霉利和乙烯菌核利在体外和体内均能拮抗雄激素受体(AR),但异菌脲似乎并非AR拮抗剂。我们推测青春期接触异菌脲会延迟雄性大鼠的青春期发育,并减少睾丸内睾酮的产生。从出生后第23天(PND)至51/52天,对斯普拉格-道利断奶幼鼠经口灌胃给予0、50、100或200mg/kg/天的异菌脲。从PND 37开始测量青春期的起始(包皮分离(PPS)进程)。在尸检时测量器官重量、血清激素以及在刺激(+人绒毛膜促性腺激素(hCG))和未刺激(-hCG)条件下的离体睾丸类固醇激素产生。异菌脲在100和200mg/kg/天剂量下延迟了PPS,在200mg/kg/天剂量下降低了雄激素敏感的精囊和附睾重量。此外,异菌脲在200mg/kg/天剂量下增加了肾上腺和肝脏重量,推测是通过不同作用机制。血清睾酮水平以及血清17α-羟孕酮和雄烯二酮水平降低,而血清促黄体生成素(LH)未受影响。异菌脲降低了离体睾丸睾酮和孕酮的产生。综上所述,这些结果表明异菌脲影响睾丸内的类固醇生成,并非通过破坏LH信号,而是可能通过在细胞色素P450 17α(CYP17)之前对类固醇生成途径的酶抑制作用。这些数据,连同报道的异菌脲在体外未能引发AR拮抗作用,提供了证据表明异菌脲与二羧酰亚胺类的腐霉利和乙烯菌核利不同,其对雄性大鼠青春期发育的影响是由类固醇生成抑制而非AR拮抗作用导致的。